We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Endpoint Assays for in vivo AST and LDH Measurement

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Endpoint Assays for in vivo AST and LDH Measurement"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The MaxDiscovery Aspartate Transaminase (AST) and Lactate Dehydrogenase (LDH) Color Endpoint Assays permit visible detection of in vivo toxicity using only 5 µL of serum from rodents or other mammals. These novel assays employ simplified endpoint analysis to offer high sensitivity, low detection limits and the ability to use a visible plate reader.

The MaxDiscovery Aspartate Transaminase (AST) kit permits quantitative visible determination of AST in a convenient format. The MaxDiscovery LDH Color Endpoint Assay kit measures the direct chemical conversion of LDH; and unlike traditional protocols, does not rely on coupled enzymatic amplification for high precision, quantitative measurements. Each kit contains ready-to-use product standards for the development of standard curves and calibration of the assay.